We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Amarna Therapeutics Appoints Kite Pharma Veteran Dr. Markwin Velders to its Supervisory Board

News   Oct 30, 2020 | Original story from Amarna Therapeutics

 
Amarna Therapeutics Appoints Kite Pharma Veteran Dr. Markwin Velders to its Supervisory Board

Dr. Markwin Velders. Credit: Amarna Therapeutics

 
 
Advertisement
 

RELATED ARTICLES

Targeting Calcium Overload Could Improve Stroke Outcomes

News

Researchers have established that excessive calcium contributes to harmful inflammation in ischemic stroke, and targeting it may provide doctors with a new way to improve patient outcomes.

READ MORE

New Type of Immunotherapy Developed To Fight Cancer

News

A new study reports on a new kind of immunotherapy that gives hope of more treatment options for cancer in the future.

READ MORE

Therapeutic Cancer Vaccine Demonstrates Good Safety and Efficacy in Preclinical Study

News

A checkpoint inhibitor vaccine known as PD1-Vaxx was shown to be safe and effective in a colon cancer syngeneic animal model.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE